POLYMED.BOPOLYMED.BOBSE
Loading
EBITDA as a percentage of revenue
3Y CAGR
+5.7%/yr
vs -0.0%/yr prior
5Y CAGR
+2.7%/yr
Consistent
Acceleration
+5.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 27.08% | +4.1% |
| 2024 | 26.00% | +8.3% |
| 2023 | 24.01% | +4.6% |
| 2022 | 22.94% | -15.1% |
| 2021 | 27.02% | +14.2% |
| 2020 | 23.67% | +11.1% |
| 2019 | 21.31% | -7.2% |
| 2018 | 22.96% | +13.3% |
| 2017 | 20.26% | -2.6% |
| 2016 | 20.81% | - |